Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Advanced Micro Devices (AMD) vs Sana Biotechnology Inc (SANA) Price & Performance

Advanced Micro DevicesTrade
Sana Biotechnology IncTrade

Price performance (Past 24H)

Key statistics

Advanced Micro Devices vs Sana Biotechnology Inc — how do they compare? Advanced Micro Devices trades at $482.36 (market cap $774.32B), while Sana Biotechnology Inc trades at $3.79 (market cap $1.13B). The key difference: Advanced Micro Devices is far larger — about 685.2× Sana Biotechnology Inc's market cap, and Advanced Micro Devices is trading nearer its 52-week high, Sana Biotechnology Inc nearer its low. Which is the better fit depends on your goals.

AMDSANA
Market Cap
$774.32B$1.13B
Sector
TechnologyHealth
52-Week High
$580.91$5.92
52-Week Low
$151.14$2.68
Enterprise Value
$765.48B$1.05B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Advanced Micro Devices

AMD's stock trades at $469.56, down 2.86% over 24 hours, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong Q2 2026 earnings, beating estimates with EPS of $1.66, and shows robust revenue growth, with 2025 revenue reaching $34.64 billion and net income of $4.34 billion. Valuation ratios remain elevated, with a P/E of 121 and P/S of 18.94, reflecting high market expectations amid surging AI demand.

Outlook is supported by AI-driven growth and consistent earnings beats, but risks include intense competition and rich valuations. Analysts maintain a bullish consensus with a $619.54 price target, though near-term volatility may persist due to technical pressure and macroeconomic factors.

Sana Biotechnology Inc

SANA Biotechnology trades at $3.77, up 4.43% on the day, with a bullish technical signal from moving averages and oscillators despite overbought RSI readings. The company reported a net loss of $244.17 million in 2025, with negative cash flow from operations, but analyst sentiment is strong with 82% buy ratings. Recent news highlights clinical data presentations and a $9.50 consensus price target from brokerages as of July 30, 2026.

The outlook hinges on clinical progress in engineered cell therapies, with upside potential from positive trial outcomes, but risks include persistent cash burn and execution challenges. Investors face high volatility given the pre-revenue biotech profile and dependence on financing activities to sustain operations.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Advanced Micro Devices

Advanced Micro Devices, Inc. (AMD) produces semiconductor products and devices. The Company offers products such as microprocessors, embedded microprocessors, chipsets, graphics, video and multimedia products and supplies it to third-party foundries, as well as provides assembling, testing, and packaging services. AMD serves customers worldwide.

Read more on AMD

About Sana Biotechnology Inc

Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.

Read more on SANA